Product
Genotype
2 clinical trials
2 indications
Indication
Glioblastoma MultiformeClinical trial
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:Status: Active (not recruiting), Estimated PCD: 2025-03-30